CYDY

CytoDyn (QB) Stock Price

5.215
-0.125 (-2.34%)
5.215
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
CytoDyn Inc (QB) CYDY OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.125 -2.34% 5.215 4.65 5.90 5.43 5.34 16:59:04
Bid Price Ask Price Spread Spread % News
5.14 5.35 0.21 3.93% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
9,847 8,690,082 $ 5.2785 $ 45,870,846 7,455,338 0.261 - 10.01
Last Trade Time Type Quantity Stock Price Currency
16:06:19 average 290,000 $ 4.9975 USD

CytoDyn (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.82B 541.03M 302.11M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
9.23M $ - 0.00% - -

more financials information »

CytoDyn (QB) News

Date Time Source News Article
7/08/202017:07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)
7/08/202016:31Edgar (US Regulatory)Current Report Filing (8-k)
6/19/202017:19Edgar (US Regulatory)Current Report Filing (8-k)
6/08/202019:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
6/08/202017:28Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)
6/08/202006:02Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting..
6/02/202017:01Edgar (US Regulatory)Current Report Filing (8-k)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CYDY Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week7.147.254.655.859,593,992-1.93-26.96%
1 Month2.9910.012.905.7311,443,7992.2374.41%
3 Months2.3910.012.114.417,466,0562.83118.2%
6 Months0.85910.010.793.196,648,9024.36507.1%
1 Year0.413610.010.2612.823,820,7814.801,160.88%
3 Years0.7710.010.05522.521,478,7644.45577.27%
5 Years0.8310.010.05522.37978,0004.39528.31%

CytoDyn (QB) Description

CytoDyn Inc. is a late-stage biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Leronlimab is in a class of therapeutic monoclonal antibodies designed to address unmet medical needs in the areas of Human Immunodeficiency Virus (HIV), Cancer, and Immunology.
Your Recent History
USOTC
CYDY
CytoDyn (Q..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200709 21:28:16